Attention & ADHD

Attention & ADHD: A Nutritional and Natural Health Reference

1. Definition and Clinical Presentation

Attention-Deficit/Hyperactivity Disorder (ADHD) is a prevalent psychiatric condition characterized by developmentally inappropriate symptoms of inattention and/or hyperactivity-impulsivity. According to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), ADHD is characterized by inattention, impulsivity, and hyperactivity.

The DSM-5 describes inattention, impulsivity, impaired inhibition, and hyperactivity as the most common ADHD symptoms, giving rise to problems in everyday life, social, academic, and occupational domains. More specific deficits in higher cognitive functions — executive functions — have often been demonstrated in ADHD. Deficits have frequently been reported in working memory, response inhibition, cognitive flexibility, risk taking, and planning.

ADHD is a frequent and disabling condition in school children, with cognitive and behavioral symptoms persisting into adulthood in a majority of patients. ADHD is a neurodevelopmental disorder common from childhood to adulthood, affecting 5% to 12% among the general population in developed countries.

Motor difficulties, such as problems with sensory motor coordination, including poor handwriting, clumsiness, and marked delays in achieving motor milestones, have also been reported and the prevalence of motor impairment in the ADHD population has been estimated to be approximately 50%. Motor problems might be partially related to abnormalities in structure and/or function of the cerebellum and basal ganglia found in ADHD.

2. Body Systems and Neurobiology Involved

Brain Structure

ADHD is a brain-based disorder with structural and functional abnormalities in widespread but specific areas of the brain. The most significant and consistent structural imaging findings include smaller total brain volumes, and reduced volumes in the right frontal lobe, right parietal cortex, caudate nucleus, cerebellar hemispheres, and posterior-inferior lobules of the cerebellar vermis.

Studies have found that ADHD is associated with weaker function and structure of prefrontal cortex (PFC) circuits, especially in the right hemisphere. Functional neuroimaging has shown widespread dysfunction in neural systems involving the prefrontal, striatal, and parietal brain regions, and has led to a brain model of deficits in multiple developmental pathways.

Neurotransmitter Systems

ADHD involves hypofunction of catecholaminergic circuits, particularly those that project to the prefrontal cortex. The PFC requires optimal levels of norepinephrine (NE) and dopamine (DA) for proper functioning. Key symptoms of ADHD, such as impulsivity, hyperactivity, and inattention, are regularly improved by dopaminergic agonists, leading to consideration of dopaminergic dysfunction as a possibly contributing factor in ADHD. Norepinephrine agonists also have clinical efficacy on ADHD symptoms, and dysfunction of neurotransmitter systems has been related to impairments of sustained attention, inhibitory control, and working memory.

Reward and Affective Systems

The reward system may be strongly involved in many functions impaired in ADHD subjects, and its breakdown or dysfunction may be critical for a variety of behavioral abnormalities. Current theories emphasize the central role of attentional and executive dysfunctions in children, as well as affective components involving emotional control and motivational processes.

Executive Function

One particular executive process, inhibition, is now considered to be a core deficit. ADHD involves a complex neurobiology that results from the interaction between various dysfunctional neurophysiological systems, as evidenced by genomic studies.

3. Contributing and Associated Factors

Genetic Factors

Twin research indicates moderate-to-large genetic contributions; the estimated heritability for ADHD is 30–80%, depending on the age, the assessment method used, and the informants. Despite ADHD being a highly heritable disorder, most candidate genes with replicated findings across association studies only account for a small proportion of genetic variance.

A minimum of 18 genes have been reported to be associated with the disorder; among them the DRD4 7-repeat allele has been found associated with a thinner prefrontal and posterior parietal cortex. Genetic studies have consistently noted alterations in genes involved in catecholamine transmission in patients with ADHD.

Environmental and Prenatal Factors

Apart from genetic risk factors, emphasis has been put on the early environment, and prenatal exposure to nicotine, alcohol, prematurity, and low birth weight have been associated with subsequent ADHD symptoms. Having a biological relative with ADHD, large rare copy number variants, some small-effect-size candidate gene variants, extreme early adversity, pre- and postnatal exposure to lead, and low birth weight/prematurity have been most consistently found as risk factors, but none are yet known to be definitely causal.

Gene–Environment Interactions

Although earlier research has shown that individual differences on the spectrum of ADHD are highly heritable, emerging evidence suggests that symptoms are associated with complex interactions between genes and environmental influences. In the last two decades, research into the etiology of ADHD has revealed significant progress in understanding its multifactorial causes. Both genetic and environmental contributions play critical roles, with an increasing focus on how these factors interact.

Research suggests that genetic factors play a more prominent role in individual differences of ADHD symptoms in the presence of high consumption of sugar and unhealthy foods. Results from nutrigenomics studies suggested that a high-sugar diet remodelled fundamental aspects of gene regulation — such as differential DNA methylation, differential gene expression, and alternative splicing — that have the potential to impact pathways relevant to ADHD.

Gut–Brain Axis

The role of gut microecology in ADHD has garnered growing attention, with studies suggesting a potential link between ADHD development and an imbalance in gut microbiota composition. A prospective study suggested that the early life microbial environment may be associated with the development of behavioral problems during childhood; however, the observational design did not allow establishing causality.

One study showed that babies with higher levels of Bifidobacterium in their gut microbiota had a lower risk of developing ADHD in the future. A birth cohort study published in 2023 showed that early life gut microbiome characteristics were linked to ADHD development by age 10; the gut microbiota of children with ADHD at 6 months of age was characterized by a lack of lactic acid bacteria like Lactobacillales and Enterococcaceae.

4. Nutrients Studied in Relation to ADHD

Multiple research studies have demonstrated that children with ADHD exhibit decreased amounts of elements including zinc, iron, copper, magnesium, and selenium in their plasma. Research shows that patients with ADHD may have reduced levels of vitamin D, zinc, ferritin, and magnesium — nutrients that have important roles in neurologic function, including involvement in neurotransmitter synthesis.

Omega-3 Polyunsaturated Fatty Acids (PUFAs)

Scientific Evidence: Omega-3 PUFAs have gained attention as a potential adjunctive treatment for ADHD due to their roles in cognitive and neurobiological functions such as attention and focus, impulse control, executive function, working memory, and neurotransmitter regulation, as well as brain development, mainly in the prefrontal cortex.

A meta-analysis of 9 studies (n=586) found lower overall blood levels of omega-3 in individuals with ADHD versus controls. A meta-analysis of 16 studies (n=1,408) found that omega-3 supplementation improved ADHD composite symptoms (g=0.26, 95% CI=0.15–0.37; p<0.001). Supplementation showed reliable effects on hyperactivity by parent and teacher report, but reliable effects for inattention only by parent report.

In seven RCTs totalling n=534 randomized youth with ADHD, omega-3 PUFA supplementation improved ADHD clinical symptom scores (g=0.38, p<0.0001).

Previous studies have shown conflicting results for the effectiveness of omega-3 PUFAs in improving ADHD symptoms, and this inconsistency may be due to differences in dosage, composition, and treatment duration. Overall, the evidence characterizes omega-3 supplementation as producing modest but statistically significant improvements, with effect sizes smaller than those seen with pharmacological interventions.

Iron

Scientific Evidence: Iron is an essential cofactor required for a number of functions, such as transport of oxygen, immune function, cellular respiration, neurotransmitter metabolism (dopamine production), and DNA synthesis. Meta-analyses have revealed that serum ferritin levels were significantly lower in children with ADHD and that there was a significant correlation between iron deficiency and the severity of ADHD symptoms. The effect of iron supplementation in ADHD children with ferritin <30 ng/mL was found to be beneficial in reducing symptoms.

Epidemiological studies have found that iron and zinc deficiencies are common nutritional deficits worldwide, with important roles in neurologic functions (poor memory, inattentiveness, and impulsiveness), and altered levels of iron and zinc have been related to the aggravation and progression of ADHD. Evidence is characterized as preliminary-to-moderate, with supplementation appearing most beneficial in children who are actually iron-deficient.

Zinc

Scientific Evidence: Children with ADHD have been observed to have significantly lower serum levels of zinc compared to neurotypical children, and, given that zinc is essential to support neurotransmitter synthesis and regulation reactions, it appears that optimizing zinc levels is beneficial in reducing ADHD symptoms.

In a randomized trial by Arnold et al. (n=52 ADHD children treated with d-amphetamine and zinc complementation at 15 mg/day or 30 mg/day), a similar improvement in ADHD was observed across all conditions, though teachers' ratings showed medium effect sizes favoring zinc while parents' reports showed an opposite trend favoring placebo. An overall systematic review of 11 RCTs showed no predominant evidence for mineral supplementation in children with ADHD. Evidence strength for zinc is characterized as mixed to moderate.

Magnesium

Scientific Evidence: There is preliminary evidence to suggest that magnesium may be promising to reduce the symptoms of ADHD. There are six reported studies using magnesium as an intervention for ADHD, of which three had a control group. The largest study was an observational study of 810 children (5–12 years of age) with symptoms of inattention and behavioral problems, supplemented with 80 mg of magnesium, zinc, EPA, DHA, and gamma-linolenic acid. After 12 weeks, there was a reduction in symptoms of inattention as well as hyperactivity/impulsivity. In children with ADHD, one study showed improvement in the clinical symptoms of ADHD with a magnesium–vitamin B6 regimen (6 mg/kg/day Mg, 0.6 mg/kg/day vitamin B6). Evidence is preliminary and most studies are small or lack adequate controls.

Vitamin D

Scientific Evidence: Research shows that patients with ADHD may have reduced levels of vitamin D. A systematic review and meta-analysis found a small but clinically meaningful effect of vitamin D supplementation as an add-on to methylphenidate for ADHD total scores compared to placebo (SMD = −0.39, 95% CI = −0.65 to −0.12). Effects vary by vitamin type and disorder; vitamin D supplementation showed greater efficacy in improving ADHD symptoms compared to vitamin B supplementation in a 2025 meta-analysis. Evidence is preliminary; most positive findings come from populations with documented deficiency, and independent replication outside particular geographic regions is needed.

B Vitamins

Scientific Evidence: Recent studies show that deficiencies in vitamins such as D, B6, B12, and folate are common in people with ADHD and are associated with behavioral, cognitive, and brain development issues. Broad-spectrum micronutrient formulas addressing cumulative mild insufficiencies — including B vitamins, magnesium, iron, and zinc — have been studied in adults with ADHD by Rucklidge et al. (2014–2021), showing that formulas containing 25 or more nutrients reduced inattention, impulsivity, aggression, and emotional dysregulation. Benefits were observed even without formal deficiencies, suggesting subclinical needs or increased metabolic demand in ADHD brains.

A notable multi-site RCT, the MADDY Study (Micronutrients for ADHD in Youth) — a rigorous three-site randomized controlled trial conducted across Oregon Health & Science University, Ohio State University, and the University of Lethbridge — found that children taking a 36-ingredient micronutrient formula were three times more likely to show significant global improvement compared to placebo. This is considered one of the more methodologically robust studies in the micronutrient-ADHD field, though it used a complex multi-ingredient formula, making it impossible to isolate the contribution of individual B vitamins.

5. Herbs and Botanical Ingredients Studied in Relation to ADHD

Bacopa monnieri (Brahmi)

Traditional Use: Bacopa monnieri is an Ayurvedic medicinal herb widely used as a tonic and memory enhancer. Bacopa monnieri, also known as Brahmi, has shown promising results in supporting individuals with symptoms of restlessness, lack of self-control, attention-deficit symptoms, learning problems, impulsivity, and psychiatric issues. In Ayurvedic medicine, it has historically been prepared as a decoction or ghee infusion and administered to children to improve memory and cognitive function.

Scientific Evidence: Seven RCTs involving children and adolescents diagnosed with ADHD met inclusion criteria in a systematic review and meta-analysis on phytotherapy for ADHD; there is a fair indication of the efficacy and safety of Bacopa monnieri for the treatment of various symptoms of ADHD from the studies evaluated. Evidence is preliminary and limited by small sample sizes; the overall strength of the evidence base is characterized as early-stage.

Ginkgo biloba

Traditional Use: Ginkgo biloba has been used in traditional Chinese medicine for millennia, primarily to improve cognitive clarity and circulation. Leaf extracts have been employed in various East Asian herbal traditions for memory and attentional support.

Scientific Evidence: There is insufficient evidence to support the use of ginkgo biloba for ADHD symptoms. In a single study comparing ginkgo biloba with methylphenidate, ginkgo biloba was less effective than the conventional pharmacologic treatment. In a 2010 randomized controlled trial, 50 children with ADHD received either ginkgo biloba or methylphenidate daily for 6 weeks; findings suggest that the administration of ginkgo biloba is less efficacious than methylphenidate in the treatment of ADHD. Limited evidence was found for Ginkgo biloba in a 2022 systematic review and meta-analysis of phytotherapy for ADHD.

Pycnogenol (French Maritime Pine Bark Extract)

Traditional Use: Pycnogenol is a standardized extract derived from the bark of Pinus pinaster, the French maritime pine. Its use as an antioxidant botanical agent developed in the 20th century; it does not have deep roots in traditional herbal medicine in the same way as Ayurvedic or Chinese herbs.

Scientific Evidence: A 2016 review found several studies of Pycnogenol that show its potentiality in improving ADHD symptoms. The review concluded that Pycnogenol is a promising botanical in the management of ADHD symptoms, although more studies are needed before it should be used as a treatment for ADHD. A total of 61 children and adolescents in one study who received Pycnogenol (1 mg/kg/day for 1 month) experienced significant improvements in hyperactivity, inattention, and visual-motor coordination compared with placebo recipients, and symptoms returned to pre-treatment levels after washout. There is insufficient evidence on the safety of Pycnogenol for ADHD to draw definitive conclusions, per NIH/NCCIH.

Crocus sativus (Saffron)

Traditional Use: Saffron is a spice extracted from the saffron crocus (Crocus sativus) that has traditionally been used as an additive and food colorant worldwide, but also as a natural remedy for several diseases given its anti-inflammatory and antioxidant properties. Saffron has been used historically to treat chronic diseases such as rheumatoid arthritis, inflammatory bowel diseases, and Alzheimer's disease.

Scientific Evidence: There is increasing evidence that saffron, probably due to some key constituents — namely, crocin, picrocrocin, and safranal — exerts protection of the central nervous system. Systematic review evidence has found that saffron (Crocus sativus) had similar efficacy compared to methylphenidate (MPH) in clinical studies in children and adolescents with ADHD. Saffron extract performed comparably to methylphenidate in smaller clinical trials, though larger studies are needed. Overall evidence strength is preliminary; findings come from a small number of studies, many of which are non-blinded or conducted at single centers.

Melissa officinalis (Lemon Balm), Valeriana officinalis (Valerian), and Matricaria chamomilla (Chamomile)

Traditional Use: These three European medicinal herbs have long histories of use in Western herbal traditions as nervines — herbs used to calm the nervous system, support sleep, and reduce anxiety and restlessness. Valerian root and lemon balm have been prepared as teas, tinctures, and standardized extracts across European folk and phytomedicinal traditions for centuries.

Scientific Evidence: Seven RCTs involving children and adolescents diagnosed with ADHD were identified in a 2022 systematic review and meta-analysis; there is a fair indication of the efficacy and safety of Melissa officinalis, Matricaria chamomilla, and Valeriana officinalis for the treatment of various symptoms of ADHD from the studies evaluated. These herbs have been studied for their effects on ADHD symptoms, but most of these studies have been small and have had methodological issues. Evidence strength is characterized as preliminary and inconclusive.

Hypericum perforatum (St. John's Wort)

Traditional Use: St. John's Wort has been used in European herbal medicine for centuries for mood disorders, anxiety, and nervous exhaustion.

Scientific Evidence: Systematic review evidence found that Hypericum perforatum was ineffective for ADHD in clinical trial data. Its use specifically for ADHD is not supported by the available evidence.

6. Dietary Patterns and Food-Related Factors

Overall Dietary Quality

Inverse associations between adherence to "healthy" diets and ADHD symptoms have been observed. Nutrition is currently considered an influencing factor in ADHD, and several studies have explored the contribution of restriction and dietary supplements in ADHD treatments.

Artificial Food Colors (AFCs) and Food Additives

Research into the effect of food on ADHD started approximately forty years ago when pediatric allergist Benjamin Feingold hypothesized that both artificial food additives (colorings and flavors) and foods rich in salicylates might be "important etiologic agents" of the hyperkinetic syndrome.

The most recent meta-analysis found that artificial food colors had an overall effect size of 0.283 (95% CI 0.079 to 0.488) on the hyperactivity score, falling to 0.210 (0.007 to 0.414) after excluding the smallest and lowest quality trials. While several meta-analyses have shown statistically significant but small adverse effects of artificial food colorants on ADHD symptoms, there is no convincing evidence of the efficacy of food color elimination in the treatment of ADHD; beneficial effects of excluding food colors may be limited to children selected for food sensitivities.

In one sample of 76 hyperactive children, 48 foods showed evidence of symptom deterioration on being added back to the diet; colors and preservatives were the most frequent offenders, but were not the sole problem in most children.

The Few-Foods (Oligoantigenic) Diet

Children with ADHD responding to the few-foods diet (or oligoantigenic diet), with an elimination of individually identified food items, show substantially improved behavior and cognitive functioning. The focus of elimination diets is to remove specific foods from the diet in an effort to eliminate potential allergens that occur naturally in food (e.g., eggs, wheat, dairy, soy) or artificial ingredients that may have allergenic or toxicant effects (e.g., synthetic food additives, artificial colors, flavors, sweeteners, flavor enhancers, and preservatives). Evidence from meta-analyses of double-blind placebo-controlled trials supports a real but modest effect in children with food sensitivities; the evidence base for the general ADHD population is less compelling.

Sugar and High-Glycemic Diets

In middle-aged adults, genetic influences on inattention symptoms were statistically significantly higher among individuals with higher levels of high-sugar food intake (45%, 95% CI: 25–54%) compared with those with lower levels of high-sugar food consumption (36%, 95% CI: 25–47%), suggesting diet may modulate gene expression relevant to ADHD. This finding comes from a population-based twin study (n=1,518 pairs) and characterizes the relationship as gene-environment interaction rather than a simple causal dietary effect.

7. Lifestyle Factors

Physical Exercise

A review on the effect of physical exercise on the physiology of childhood ADHD stressed that physical activity and stimulant medication both affect the dopaminergic and noradrenergic systems. The main cumulative evidence from a systematic review and meta-analysis indicates that short-term aerobic exercise, based on several aerobic intervention formats, seems to be effective for mitigating symptoms such as attention, hyperactivity, impulsivity, anxiety, executive function, and social disorders in children with ADHD.

A network meta-analysis found that all types of physical exercise were effective in improving executive functions (SMD = 1.15, 95% CI: 0.83 to 1.46), and open-skill activities — which require participants to react in a dynamically changing and externally paced environment — induced the most considerable benefits for executive functions.

A 2025 meta-analysis found that both acute exercise (SMD = −0.65, 95% CI = −1.10 to −0.20, P = 0.005) and chronic exercise (SMD = −1.77, 95% CI = −2.84 to −0.69, P = 0.0001) have a positive effect on the inhibitory control of adult ADHD.

Chronic physical exercise positively affects brain structure (e.g., improved white matter integrity) and function (e.g., increased activation in brain regions including the anterior cingulate and superior frontal gyrus), while moderate-intensity chronic exercise, through different mechanisms, has been found to enhance neurotransmitter systems, upregulate BDNF, increase neurogenesis, and improve psychological well-being.

Sleep

Sleep disorders represent one of the most frequent comorbidities in children with ADHD. Adequate sleep helps maintain a healthy gut-brain connection and supports optimal microbiome function, which is particularly important for ADHD symptom regulation.

Stress

Chronic stress can negatively affect both gut and brain health, potentially exacerbating ADHD symptoms.

Gut Microbiome and Probiotics

The relationship between the gut microbiome and their host is bidirectional, so that human beings also regulate the composition and number of the microorganisms that colonize the digestive tract through factors related to diet, health, and lifestyle. Emerging research suggests potential therapeutic applications specifically for ADHD, as targeted probiotic treatments may help address specific ADHD symptoms through gut-brain axis modulation. This is an active and early-stage area of research; no specific probiotic regimen has sufficient clinical evidence to support formal recommendations.

References

• Curatolo P et al. "The neurobiological basis of ADHD." PMC/NIH.
• Arnsten AF. "The neurobiology of attention deficit/hyperactivity disorder." PubMed.
• Arnsten AF. "The Emerging Neurobiology of ADHD: The Key Role of the Prefrontal Association Cortex." PMC/NIH.
• Montoya A et al. "An overview on neurobiology and therapeutics of ADHD." Discover Mental Health, Springer Nature, 2023.
• Thapar A et al. "Practitioner Review: What have we learnt about the causes of ADHD?" PMC/NIH.
• Jangmo A et al. "Gene-Environment Interactions in ADHD Symptom Dimensions: The Role of Unhealthy Food Habits." PMC/NIH, 2022.
• "Unraveling ADHD Etiology: Current Challenges and Future Directions in Treatment." PMC/NIH, 2025.
• Hawkey E, Nigg JT. "Omega-3 fatty acid and ADHD: Blood level analysis and meta-analytic extension of supplementation trials." PMC/NIH, 2014.
• Bègue L et al. "Omega-3 PUFAs in Youths with ADHD: a Systematic Review and Meta-Analysis." Neuropsychopharmacology, 2017.
• Villagomez A, Ramtekkar U. "Iron, Magnesium, Vitamin D, and Zinc Deficiencies in Children Presenting with Symptoms of ADHD." PMC/NIH, 2014.
• Villagomez A et al. "The Role of Iron and Zinc in the Treatment of ADHD among Children and Adolescents: A Systematic Review of RCTs." PMC/NIH, 2021.
• "Magnesium, Iron, and Zinc Supplementation for the Treatment of ADHD." International Journal of Preventive Medicine, 2015.
• "The association between serum vitamin D and ADHD: a systematic review and meta-analysis." Middle East Current Psychiatry, 2025.
• Shen Y et al. "Vitamin Interventions in ASD and ADHD: Systematic Review and Meta-Analysis." Neuropsychiatric Disease and Treatment, 2025.
• Doaei S et al. "Phytotherapy for ADHD: A Systematic Review and Meta-analysis." Frontiers in Pharmacology / PMC, 2022.
• Golsorkhi H et al. "Herbal medicines in the treatment of children and adolescents with ADHD: An updated systematic review of clinical trials." Avicenna J Phytomed, 2023.
• NIH/NCCIH. "ADHD and Complementary Health Approaches: What the Science Says."
• "Effectivity of Saffron Extract on Treatment for Children and Adolescents with ADHD." PMC/NIH, 2022.
• "The Effects of Crocus sativus (Saffron) on ADHD: A Systematic Review." PubMed, 2023.
• Pelsser L et al. "Diet and ADHD, Reviewing the Evidence: A Systematic Review of Meta-Analyses of Double-Blind Placebo-Controlled Trials." PMC/NIH, 2017.
• Nigg JT, Holton K. "Restriction and Elimination Diets in ADHD Treatment." PMC/NIH, 2014.
• "Food additives and hyperactivity." PMC/NIH, BMJ.
• "Nutrition in the Management of ADHD: A Review of Recent Research." PMC/NIH, 2023.
• "Current Evidence on the Role of the Gut Microbiome in ADHD Pathophysiology and Therapeutic Implications." PMC/NIH, 2021.
• "A narrative review of research advances in gut microbiota and microecological agents in children with ADHD." PMC/NIH, 2025.
• Hoza B et al. "Sweat it out? The effects of physical exercise on cognition and behavior in children and adults with ADHD." PMC/NIH, 2017.
• Cerrillo-Urbina AJ et al. "The effects of physical exercise in children with ADHD: a systematic review and meta-analysis of RCTs." PubMed, 2015.
• "Comparative effectiveness of various physical exercise interventions on executive functions in children and adolescents with ADHD: A systematic review and network meta-analysis." PMC/NIH, 2023.
• "The impact of physical activity on inhibitory control of adult ADHD: a systematic review and meta-analysis." Journal of Global Health, 2025.
• "The efficacy of physical exercise interventions on mental health, cognitive function, and ADHD symptoms in children and adolescents with ADHD: an umbrella review." eClinicalMedicine / The Lancet, 2023.